Theradaptive Company
Theradaptive is transforming the delivery of protein therapeutics by leveraging its platform technology to convert any protein into a material binding variant. This permits ultra precise and controlled delivery and retention of protein therapeutics at specific sites within the body. This platform has allowed the company to create therapeutics in several clinical indications including spinal fusion, soft tissue repair, localized oncology treatment, cartilage repair, and several other regenerative medicine applications.
Founded Date:
2016-05-02
Last Funding Type:
Series A
Headquarters:
Boston, Massachusetts, United States
Investors Number:
6
Technology:
Other
Employee Number:
1-10
Industry:
BioTech
Estimated Revenue:
$1M to $10M
Total Funding:
$10.5M